Correlation Between Regencell Bioscience and Petros Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regencell Bioscience and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regencell Bioscience and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regencell Bioscience Holdings and Petros Pharmaceuticals, you can compare the effects of market volatilities on Regencell Bioscience and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regencell Bioscience with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regencell Bioscience and Petros Pharmaceuticals.

Diversification Opportunities for Regencell Bioscience and Petros Pharmaceuticals

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Regencell and Petros is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Regencell Bioscience Holdings and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and Regencell Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regencell Bioscience Holdings are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of Regencell Bioscience i.e., Regencell Bioscience and Petros Pharmaceuticals go up and down completely randomly.

Pair Corralation between Regencell Bioscience and Petros Pharmaceuticals

Considering the 90-day investment horizon Regencell Bioscience Holdings is expected to generate 2.4 times more return on investment than Petros Pharmaceuticals. However, Regencell Bioscience is 2.4 times more volatile than Petros Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Petros Pharmaceuticals is currently generating about -0.4 per unit of risk. If you would invest  610.00  in Regencell Bioscience Holdings on August 28, 2024 and sell it today you would lose (19.00) from holding Regencell Bioscience Holdings or give up 3.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Regencell Bioscience Holdings  vs.  Petros Pharmaceuticals

 Performance 
       Timeline  
Regencell Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regencell Bioscience Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Regencell Bioscience is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Petros Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Petros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Regencell Bioscience and Petros Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regencell Bioscience and Petros Pharmaceuticals

The main advantage of trading using opposite Regencell Bioscience and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regencell Bioscience position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.
The idea behind Regencell Bioscience Holdings and Petros Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments